(Circulation. 1997;95:560-561.)
© 1997 American Heart Association, Inc.
Articles |
the Indiana University Medical Center (H.O.S., A.D.B.) and the Richard L. Roudebush VA Medical Center, Indianapolis, Ind.
Correspondence to Alain D. Baron, MD, Department of Medicine, Indiana University Medical Center, 541 N Clinical Dr, CL459, Indianapolis, IN 46202-5111.
Key Words: Editorials acetylcholine nervous system, autonomic regional blood flow vasodilation
| Introduction |
|---|
|
|
|---|
The article by Makimattila and colleagues14 in this issue sheds some light on this complex problem. The authors assessed changes in forearm blood flow to the endothelium-dependent vasodilator ACh, the endothelium-independent vasodilator SNP, and the inhibitor of NO synthase L-NMMA in controls and in IDDM subjects. IDDM subjects were characterized by either normal or massively elevated albumin excretion (macroalbuminuria), which is a marker for increased risk of cardiovascular mortality and has been reported to be associated with severe endothelial dysfunction.15 It is important to note that, unlike previous studies, this study14 controlled for blood glucose and insulin levels while studying vascular responsiveness, thus removing important potential confounding factors. The authors also measured autonomic responses to a host of stimuli with the use of sophisticated techniques to uncover subtle autonomic dysfunction. The relationship between blood flow responses and indices of autonomic function were then evaluated by simple correlation and multiple linear regression analyses. The novel and unexpected findings are that subjects with macroalbuminuria exhibit higher blood flow responses to ACh and SNP and that the magnitude of response in IDDM subjects is directly related to the severity of autonomic dysfunction. While the study design is sound, some caveats are noteworthy: (1) the studies are performed at the high end of the dose-response curve for ACh. Thus, differences that may have occurred at lower concentrations could have been missed. (2) The maximal response to ACh in the controls was twofold, while it has been reported to be greater than fourfold1 3 4 at a similar ACh dose, ie, comparable to the response in macroalbuminuric patients. This discrepancy should not affect the relative difference in vascular responses to ACh between groups. However, if responses in the control group were uniquely low (for whatever reason) differences between normal and macroalbuminuric IDDM may have been overestimated. In other words, the vascular response to ACh in normal and macroalbuminuric IDDM subjects may actually be comparable, but the normoalbuminuric IDDM may have decreased response to ACh.
These caveats notwithstanding, the interpretation of the current results is not straightforward because NO-dependent vasodilation is determined by both the magnitude of NO release by the endothelium and the sensitivity and responsiveness of the VSMC to NO. Thus, increased vasodilatory responses could be due to (1) higher rates of NO production or reduced NO clearance, (2) increased sensitivity of the vascular smooth muscle, and/or (3) decreased sympathetic vasoconstrictor tone. Scenario 1 cannot account for the enhanced response to SNP, which would be expected to be normal or decreased. Scenario 2 is much more likely. If the sensitivity of VSMC to NO is increased, even subnormal amounts of NO could elicit a higher blood flow response. Increased sensitivity of the VSMC would also explain the higher response to SNP. As suggested by Moncada et al,16 hypersensitivity to nitrovasodilators could be secondary to chronically reduced basal rates of NO production in the IDDM, leading to upregulation of the NO response system. Calver et al1 reported decreased response to L-NMMA in IDDM, which suggests reduced basal rates of NO production. Makimattila et al14 report normal responses to L-NMMA in IDDM, which is compatible with reduced NO production combined with increased NO sensitivity. Scenario 3 is also possible. Impaired sympathetic nervous system function could potentially lead to enhanced responses to NO or SNP. In support of this notion, Sartori and coworkers17 recently reported that insulin-mediated, endothelium-dependent vasodilation is enhanced in patients who have undergone sympathectomy. Also, local
-adrenergic blockade may increase blood flow in response to ACh.18
How does one explain the strong correlation between indices of autonomic dysfunction and blood flow responses? The hyperglycemic state could have independent effects of similar magnitude on the autonomic nervous system and the vasculature, and the correlation may just reflect the association with the IDDM. On the other hand, the strong relationship between autonomic dysfunction and the nitrosovasodilator response could reflect the progressive withdrawal of sympathetic pressor tone with long-standing diabetic neuropathy. This would change the balance between the endothelial vasodilator system and sympathetic pressor tone in favor of augmented vasodilation. Thus, taken together, increased reactivity to nitrovasodilators in IDDM patients with macroalbuminuria could be explained by hypersensitivity at the level of the VSMC and/or decreased sympathetic vasoconstrictor tone.
Clearly, these provocative data beg further study into the interaction between the autonomic nervous system and endothelial/VSMC function. Moreover, it is clear that the measurement of in vivo NO production rates in conjunction with functional measures of vascular responsiveness is required for a full understanding of the status of endothelium-dependent vasodilation in disease states.
| Selected Abbreviations and Acronyms |
|---|
|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. C. Hickner, G. Kemeny, K. McIver, K. Harrison, and M. E. Hostetler Lower Skeletal Muscle Nutritive Blood Flow in Older Women Is Related to eNOS Protein Content J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2003; 58(1): B20 - 25. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |